Skip to main content

Table 2 HS-CRP

From: Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study

Group

Baseline

8 weeks

Change

Placebo

13.10 ± 5.2

14.00 ± 8.5

+ 0.90 ± 9.5

6 oz Xango

21.30 ± 16.8

14.65 ± 8.8

- 6.65 ± 11.7

12 oz Xango

18.33 ± 9.0

11.67 ± 4.2

- 6.66 ± 5.8

18 oz Xango

12.00 ± 5.6

10.67 ± 5.6

-1.33 ± 3.0

  1. Mean HS-CRP levels plus/minus standard deviations at baseline, after 8 weeks and the change over time. None of the changes from baseline were statistically significant. However the comparison of change from baseline to 8 weeks between the 18 oz group and the placebo group was significant (p = 0.019).